Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives

EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) et al. EFSA J. .

Abstract

The present opinion deals with the re-evaluation of the safety of food-grade carrageenan (E 407) and processes Eucheuma seaweed (E 407a) used as food additives. Because of the structural similarities, the Panel concluded that processed Eucheuma seaweed can be included in the evaluation of food-grade carrageenan. Poligeenan (average molecular weight 10-20 kDa) has not been authorised as a food additive and is not used in any food applications. In its evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a), the Panel noted that the ADME database was sufficient to conclude that carrageenan was not absorbed intact; in a subchronic toxicity study performed with carrageenan almost complying with the EU specification for E 407 in rats, the no-observed-adverse-effect level (NOAEL) was 3,400-3,900 mg/kg body weight (bw) per day, the highest dose tested; no adverse effects have been detected in chronic toxicity studies with carrageenan in rats up to 7,500 mg/kg bw per day, the highest dose tested; there was no concern with respect to the carcinogenicity of carrageenan; carrageenan and processed Eucheuma seaweed did not raise a concern with respect to genotoxicity; the NOAEL of sodium and calcium carrageenan for prenatal developmental dietary toxicity studies were the highest dose tested; the safety of processed Eucheuma seaweed was sufficiently covered by the toxicological evaluation of carrageenan; data were adequate for a refined exposure assessment for 41 out of 79 food categories. However, the Panel noted uncertainties as regards the chemistry, the exposure assessment and biological and toxicological data. Overall, taking into account the lack of adequate data to address these uncertainties, the Panel concluded that the existing group acceptable daily intake (ADI) for carrageenan (E 407) and processed Eucheuma seaweed (E 407a) of 75 mg/kg bw per day should be considered temporary, while the database should be improved within 5 years after publication of this opinion.

Keywords: Carrageenan; E 407; E 407a; degraded carrageenan; food additives; processed Eucheuma seaweed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structural formula of κ‐, ι‐ and λ‐carrageenan
Figure 2
Figure 2
Examples of molecular weight profiles of poligeenan and carrageenan preparations analysed by size exclusion chromatography (SEC) and light scattering (LS). For clarity, the 200 kDa point of reference has been added. For the presented preparation of carrageenan, the weight‐average molecular weight is approximately 770 kDa (Documentation provided to EFSA n. 18 and 19)
Figure 3
Figure 3
Gelation Mechanism of Carrageenan (re‐produced from Blakemore and Harpel, 2010; Documentation provided to EFSA n.18)
Figure 4
Figure 4
Carrageenan manufacturing process flow chart (re‐produced from Blakemore and Harpel, 2010). (Documentation provided to EFSA n. 15)
Figure 5
Figure 5
Processed Eucheuma seaweed manufacturing process flow chart (re‐produced from Blakemore and Harpel, 2010; Documentation provided to EFSA n. 15)

References

    1. Abraham R, Goldberg L and Coulston F, 1972. Uptake and storage of degraded carrageenan in lysosomes of reticuloendothelial cells of the rhesus monkey, Macaca mulatta . Experimental and Molecular Pathology, 17, 77–93. - PubMed
    1. Abraham R, Fabian RJ, Golberg L and Coulston F, 1974. Gastfloenterology, 67, 1169–1181. - PubMed
    1. Abraham R, Benitz KF, Rosenblum I, Mankes RF and Ringwood N, 1983. Studies on Rhesus monkeys (Macaca mulatta) receiving native carrageenan (Chondrus crispus) orally for 7.5 years. Unpublished report from Institute of Experimental Pathology and Toxicology. Albany Medical College, Sub.
    1. Abraham R, Benitz KF, Mankes R and Rosenblum I, 1985. Chronic and subchronic effects of various forms of carrageenan in rats. Ecotoxicology and Environmental Safety, 10, 173–183. - PubMed
    1. Ackloo S, Terlouw JK, Ruttink PJ and Burgers PC, 2001. Analysis of carrageenans by matrix‐assisted laser desorption/ionization and electrospray ionization mass spectrometry. I. κ‐Carrageenans. Rapid Communications in Mass Spectrometry, 15, 1152–1159. - PubMed

LinkOut - more resources